Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TP73 | hg38_v1_chr1_+_3698027_3698058 | 0.24 | 1.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_+_74174403 Show fit | 1.78 |
ENST00000560862.1
ENST00000395118.1 |
immunoglobulin superfamily containing leucine rich repeat |
|
chr12_+_49295138 Show fit | 1.71 |
ENST00000257860.9
|
peripherin |
|
chr1_+_46671821 Show fit | 1.66 |
ENST00000334122.5
ENST00000415500.1 |
testis expressed 38 |
|
chr15_+_40844018 Show fit | 1.63 |
ENST00000344051.8
ENST00000562057.6 |
serine peptidase inhibitor, Kunitz type 1 |
|
chr2_-_165794190 Show fit | 1.61 |
ENST00000392701.8
ENST00000422973.1 |
polypeptide N-acetylgalactosaminyltransferase 3 |
|
chr2_+_176116768 Show fit | 1.49 |
ENST00000249501.5
|
homeobox D10 |
|
chr1_+_46671871 Show fit | 1.40 |
ENST00000564373.1
|
testis expressed 38 |
|
chr2_+_219572304 Show fit | 1.38 |
ENST00000243786.3
|
inhibin subunit alpha |
|
chr9_+_36169382 Show fit | 1.31 |
ENST00000335119.4
|
calicin |
|
chr19_+_44777860 Show fit | 1.30 |
ENST00000341505.4
ENST00000647358.2 |
Cbl proto-oncogene C |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 2.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 1.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 1.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 1.6 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.2 | 1.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 1.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.1 | 1.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 1.4 | GO:0046882 | negative regulation of B cell differentiation(GO:0045578) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.4 | 1.3 | GO:0008057 | eye pigment granule organization(GO:0008057) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.3 | 1.6 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.0 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 1.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.5 | 1.4 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.4 | 1.3 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.2 | 1.3 | GO:0044393 | microspike(GO:0044393) |
0.0 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 4.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 1.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 1.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 1.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 1.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 1.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 1.3 | GO:0015485 | cholesterol binding(GO:0015485) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |